Thu, Jan 14 | online meeting link in registration email

China and U.S. Collaboration in Pharmaceuticals

Webinar topics include: • An overview of the biopharma industry in China and the U.S. • Opportunities for collaboration between China and the U.S., featuring New Jersey as a case study • The regulatory environment/process in both countries • Investor insights on doing business in China and the U
Registration is Closed

Time & Location

Jan 14, 8:30 AM – 10:30 AM EST
online meeting link in registration email

About the Event

Program Agenda:

8:30 a.m.-8:40 amWelcome by BioNJ and SAPADebbie Hart, President and CEO, BioNJ John Sun, Ph.D., President, SAPA & Global Program Lead, Novartis8:40 a.m.-8:50 amNew Jersey: A Leading Hub for Medical Innovation Cathy Scangarella, Chief Business Development Officer, Choose New Jersey8:50 a.m-9:00 a.m.Biotech Market Dynamics in China  Brad Loncar, CEO, Loncar Investments9:00 a.m-9:20 a.m.The Regulatory Environment in China Sara Wang, Sr. Director, Science and Regulatory, RDPAC9:20 a.m.-9:40 a.m.The Regulatory Environment in the U.S. Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration9:40 a.m.-10:25 a.m.Panel Discussion: China and U.S. Collaboration: Innovation on the HorizonLu Cao, Managing Director, Corporate & Investment Bank, J.P. Morgan Echo Hindle-Yang, President and CEO, MSQ Ventures Stuart Peltz, Ph.D., CEO, PTC Therapeutics Lily Zou, Ph.D., CEO, Fosun Pharma USA10:25 a.m.-10:30 a.m.Closing Remarks

Registration is Closed

Share This Event

Philadelphia, USA | Blainville, Canada | Cambridge, UK | Semengoh, Malaysia | Hangzhou, China